2008
DOI: 10.1016/j.carrev.2008.02.039
|View full text |Cite
|
Sign up to set email alerts
|

New treatment option for patients with end-stage coronary artery disease by extracorporeal shockwave myocardial revascularization therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2015
2015
2015
2015

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…, Ranolazine [ 111 ], Ivabradine [ 112 ], and Nicorandil [ 113 ]) and the existence of non- pharmacologic treatments ( e.g. , transcutaneous electrical nerve stimulation [ 114 ], spinal cord stimulation [ 115 ], enhanced external counterpulsation [ 116 ], laser transmyocardial revascularization [ 117 ], extracorporeal shockwave myocardial revascularization [ 118 ]), the problems no-option patients face have not yet been resolved.…”
Section: Nccmbf and The Issue Of ‘No-option’ Patientsmentioning
confidence: 99%
“…, Ranolazine [ 111 ], Ivabradine [ 112 ], and Nicorandil [ 113 ]) and the existence of non- pharmacologic treatments ( e.g. , transcutaneous electrical nerve stimulation [ 114 ], spinal cord stimulation [ 115 ], enhanced external counterpulsation [ 116 ], laser transmyocardial revascularization [ 117 ], extracorporeal shockwave myocardial revascularization [ 118 ]), the problems no-option patients face have not yet been resolved.…”
Section: Nccmbf and The Issue Of ‘No-option’ Patientsmentioning
confidence: 99%